Shares of Fenner PLC (LON:FENR) have earned a consensus recommendation of “Buy” from the eight research firms that are presently covering the stock, MarketBeat.com reports. Three equities research analysts have rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average 1-year price target among brokers that have updated their coverage on the stock in the last year is GBX 485 ($6.46).
FENR has been the topic of several research reports. Peel Hunt reissued a “buy” rating and set a GBX 500 ($6.66) price target on shares of Fenner in a research report on Monday, March 5th. Jefferies Financial Group raised their target price on shares of Fenner from GBX 500 ($6.66) to GBX 535 ($7.12) and gave the company a “buy” rating in a report on Thursday, February 22nd. Investec raised shares of Fenner to a “hold” rating and raised their target price for the company from GBX 425 ($5.66) to GBX 610 ($8.12) in a report on Tuesday, March 20th. Finally, Citigroup raised their target price on shares of Fenner from GBX 525 ($6.99) to GBX 610 ($8.12) and gave the company a “buy” rating in a report on Tuesday, March 20th.
Shares of FENR remained flat at $GBX 609 ($8.11) during mid-day trading on Tuesday. Fenner has a 52-week low of GBX 279 ($3.71) and a 52-week high of GBX 509.50 ($6.78).
Fenner Company Profile
Fenner PLC provides engineered products and conveyor solutions. The company's Advanced Engineered Products segment offers sealing technologies, such as seals for upstream/midstream oil and gas, petrochemicals, and fluid power; and solesis medical solutions comprising biomedical textile components and biomaterials, as well as single-use products for blood management, bioprocessing, and cell therapy.
Receive News & Ratings for Fenner Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fenner and related companies with MarketBeat.com's FREE daily email newsletter.